$GERN 3 SEC Filings

Filed On	Filing
14 Apr 2026	Form 3: Williams Timothy, EVP and Chief Legal Officer No securities owned
26 Mar 2026	Form 3: Chinoporos Constantine, Director No securities owned
26 Mar 2026	Form 3: Andrews Patricia S, Director No securities owned
20 Oct 2025	Form 3: ElNawawi Ahmed, EVP, Chief Commercial Officer Holds 10,000 shares of Common Stock
08 Aug 2025	Form 3: Semerjian Harout, Director No securities owned
12 Nov 2024	Form 3: Eid Joseph, EVP, Research and Development No securities owned
09 Sep 2024	Form 3: Ziegler James, EVP, Chief Commercial Officer No securities owned
28 Nov 2023	Form 3: Aggarwal Gaurav, Director No securities owned
27 Sep 2023	Form 3: Robertson Michelle, EVP, Chief Financial Officer No securities owned
03 Aug 2023	Form 3: Samuels Scott Alan, EVP, Chief Legal Officer No securities owned
08 Sep 2022	Form 3: McDonald John F, Director No securities owned
12 Jul 2022	Form 3: Feller Faye, EVP, Chief Medical Officer
04 Dec 2019	Form 3: Kapur Anil, EVP, Corp Strategy & CCO No securities owned
28 Mar 2019	Form 3: O'Farrell Elizabeth G., Director No securities owned
28 Mar 2019	Form 3: Bir Dawn Carter, Director No securities owned
01 Feb 2019	Form 3: Rizo Aleksandra, EVP, Chief Medical Officer No securities owned
09 Oct 2013	Form 3: Geron Corp, 10% owner · Asterias Biotherapeutics, Inc. Holds 6,537,779 shares of Series A Common Stock
06 Dec 2012	Form 3: Parker Craig C, SVP, Corporate Development
28 Sep 2012	Form 3: Molineaux Susan, Director Holds 0 shares of No securities are beneficially owned.
28 Sep 2012	Form 3: Bradbury Daniel, Director Holds 0 shares of No securities are beneficially owned.

Comments